Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. junior Avg
|
New words:
Aaron, Abstract, adenosyltransferase, agile, agility, alongside, APAC, array, Authorisation, bad, bar, barrier, BeOne, BOVen, break, breakdown, broadest, cantonal, cardiac, catalytic, CCA, CELESTIAL, chemoradiation, cholangiocarcinoma, CISO, cisplatin, clarification, CNIPA, CODM, Confederation, count, CRO, CSPC, Cuba, DCR, declaratory, discipline, divestiture, Duality, EGFRxMET, Eli, entrant, EO, epithelial, EPO, etoposide, explicitly, facebook, filer, Florida, fourteen, France, frontline, gastrointestinal, Gemcitabine, Germany, GI, gradually, grown, hard, hotline, idle, IMM, incomplete, inflection, instability, instagram, insulate, intact, intervene, Iran, Italy, Japanese, Jazz, Justice, Lenvatinib, lifecycle, Likewise, linkedin, LOQTORZI, mailing, malware, meaningfully, MENA, methionine, MoA, monopoly, Morgan, MRD, MSN, MTAP, multispecific, naive, ncBTKi, noncovalent, nottolerate, Nurix, ODD, offline, ORR, outperform, overturn, paired, PD, Pi, plc, PMDA, pneumonia, PoC, Polynucleotide, powerhouse, presence, pretreated, primed, printing, protectionist, PTE, redomicile, redomiciled, redomiciliation, redomiciling, reimportation, reinforced, remission, residential, retaliatory, Rosenberg, Roth, ROW, Sandoz, scientist, score, Shijiazhuang, societal, Spain, SPC, spectrum, startup, Subtopic, syndrome, synergistic, tablet, TAP, tariff, TEAE, theft, thirteen, thrive, ticker, TLS, trispecific, TsAb, Twitter, uMRD, underfunding, undermine, undetectable, unequivocal, unfunded, unmeasurable, unremitted, urgency, Venezuela, VGPR, wildtype, withheld, Zhongqi, ZIIHERA
Removed:
abolished, absolute, acalabrutinib, accelerating, acted, Adium, advocate, affordability, Africa, agonistic, AIRUIKA, Akeso, Alphamab, ANNIKE, antigen, appended, Apportionment, arm, ASPEN, Assembly, assigned, assumed, atezolizomab, atezolizumab, attempted, avelumab, avoid, Azymetric, BioPharma, bladder, brain, BRCA, breached, bridge, bridging, buy, call, camrelizumab, capable, Caribbean, carryforward, categorization, CCPA, cemiplimab, Chamber, CMML, comparative, comparator, compensate, compensatory, Compugen, concrete, concurrent, constant, construct, corazon, corroborative, corsee, counterclaim, covalently, CPRA, creativity, CStone, cure, cut, derivation, detected, diagnosed, dimer, diminish, disclaimed, disorder, dispute, diversity, docetaxel, donald, dostarlimab, doublet, duly, durvalumab, dysplasia, easily, embedded, enabling, engine, envafolimab, ENWEIDA, enzyme, Erkim, esg, excessive, exercising, falling, fatal, feedback, Fluzoparib, formatted, frequently, gBRCA, GC, generation, germline, glazer, Gloria, harboring, HBV, Hengrui, herewith, histology, homolog, hypomethylation, IDEA, illiquidity, immunoglobulin, immunomodulatory, impairing, inactivation, indefinite, induced, infection, ingredient, injectable, inline, innocare, Innovent, inter, interactive, invoice, ion, Israel, journal, Julia, killer, Lai, lengthened, leverage, Lichtenstein, Liechtenstein, lifirafenib, Linkbase, literature, low, MAA, macroeconomic, MAGNOLIA, manager, mandatorily, marker, maximize, medically, Medison, melanoma, Mereo, meter, Minsheng, Mirati, mirdametinib, misconduct, Missouri, monomer, murine, myeloid, myelomonocyte, myelomonocytic, Nanjing, Nanolek, nearby, NewBridge, niraparib, nivolumab, NK, noncontrolling, notifying, occasion, olaparib, omitted, oncogene, orelabrutinib, outset, parte, partnered, patentability, pembrolizumab, penpulimab, pharmacological, placement, pluripotent, poly, polymerase, preserve, principle, proliferative, propriety, proud, provoke, purporting, raf, ratifying, reassessed, recapture, redacting, Reg, reorganization, repurposed, responded, resubstitution, ROSEWOOD, rulemaking, salesforce, sarcoma, Schema, Seagen, Sereno, shelf, Shoreline, signaling, sintilimab, sitravatinib, skeletal, stead, storing, strive, stronger, structural, submitting, subscribed, sudden, sugemalimab, surface, taxonomy, TCR, terminally, text, Thailand, thereunto, therewith, thing, thought, title, toripalimab, transplant, trapping, TUOYI, Turkey, TYVYT, undergo, undersigned, underwriting, underwritten, undisclosed, unification, validation, viability, viral, weaken, window, withdrawing, workplace, XBRL, YINUOKAI, YUTUO, Zai, ZEJIEMEI, zimberelimab
Filing tables
Filing exhibits
Related press release
Associated ONC transcripts
ONC similar filings
Filing view
External links